LAMEA Metastatic Cancer Drugs Market

LAMEA Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Country and Growth Forecast, 2023 - 2030

Report Id: KBV-16554 Publication Date: July-2023 Number of Pages: 147
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 LAMEA Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Metastatic Cancer Drugs Market
TABLE 4 Product Launches And Product Expansions– Metastatic Cancer Drugs Market
TABLE 5 Acquisition and Mergers– Metastatic Cancer Drugs Market
TABLE 6 Approvals & Trials– Metastatic Cancer Drugs Market
TABLE 7 LAMEA Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 8 LAMEA Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 9 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 16 LAMEA Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 17 LAMEA Breast Cancer Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Breast Cancer Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Lung Cancer Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Lung Cancer Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Colorectal Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Colorectal Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Melanoma & Others Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Melanoma & Others Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 28 LAMEA Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 29 LAMEA Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Targeted Therapy Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Immunotherapy Market by Country, 2023 - 2030, USD Million
TABLE 33 LAMEA Hormonal Therapy Market by Country, 2019 - 2022, USD Million
TABLE 34 LAMEA Hormonal Therapy Market by Country, 2023 - 2030, USD Million
TABLE 35 LAMEA Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 36 LAMEA Chemotherapy Market by Country, 2023 - 2030, USD Million
TABLE 37 LAMEA Metastatic Cancer Drugs Market by Country, 2019 - 2022, USD Million
TABLE 38 LAMEA Metastatic Cancer Drugs Market by Country, 2023 - 2030, USD Million
TABLE 39 Brazil Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 40 Brazil Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 41 Brazil Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Brazil Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 Brazil Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 44 Brazil Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 45 Brazil Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 46 Brazil Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 47 Argentina Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 48 Argentina Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 49 Argentina Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Argentina Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Argentina Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 52 Argentina Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 53 Argentina Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 54 Argentina Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 55 UAE Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 56 UAE Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 57 UAE Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 UAE Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 UAE Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 60 UAE Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 61 UAE Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 62 UAE Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 63 Saudi Arabia Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 65 Saudi Arabia Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Saudi Arabia Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Saudi Arabia Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 68 Saudi Arabia Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 69 Saudi Arabia Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 70 Saudi Arabia Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 71 South Africa Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 72 South Africa Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 73 South Africa Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 South Africa Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 South Africa Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 76 South Africa Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 77 South Africa Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 78 South Africa Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 79 Nigeria Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 80 Nigeria Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 81 Nigeria Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Nigeria Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 83 Nigeria Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 84 Nigeria Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 85 Nigeria Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 86 Nigeria Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 87 Rest of LAMEA Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 88 Rest of LAMEA Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 89 Rest of LAMEA Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Rest of LAMEA Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 91 Rest of LAMEA Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 92 Rest of LAMEA Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 93 Rest of LAMEA Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 94 Rest of LAMEA Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 95 Key Information – Bristol Myers Squibb Company
TABLE 96 KEY INFORMATION - Merck & Co., Inc.
TABLE 97 KEY INFORMATION – AstraZeneca PLC
TABLE 98 Key Information – Novartis AG
TABLE 99 Key Information – Eli Lilly And Company
TABLE 100 Key Information – Pfizer, Inc.
TABLE 101 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 102 Key Information – Johnson & Johnson
TABLE 103 Key Information – Amgen, Inc.
TABLE 104 Key Information – Sanofi S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Metastatic Cancer Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Metastatic Cancer Drugs Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2019, Jul – 2023, Apr) Leading Players
FIG 7 Porter’s Five Forces Analysis - Metastatic Cancer Drugs Market
FIG 8 LAMEA Metastatic Cancer Drugs Market share by Distribution Channel, 2022
FIG 9 LAMEA Metastatic Cancer Drugs Market share by Distribution Channel, 2030
FIG 10 LAMEA Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2030, USD Million
FIG 11 LAMEA Metastatic Cancer Drugs Market share by Indication, 2022
FIG 12 LAMEA Metastatic Cancer Drugs Market share by Indication, 2030
FIG 13 LAMEA Metastatic Cancer Drugs Market by Indication, 2019 - 2030, USD Million
FIG 14 LAMEA Metastatic Cancer Drugs Market share by Therapy, 2022
FIG 15 LAMEA Metastatic Cancer Drugs Market share by Therapy, 2030
FIG 16 LAMEA Metastatic Cancer Drugs Market by Therapy, 2019 - 2030, USD Million
FIG 17 LAMEA Metastatic Cancer Drugs Market share by Country, 2022
FIG 18 LAMEA Metastatic Cancer Drugs Market share by Country, 2030
FIG 19 LAMEA Metastatic Cancer Drugs Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Bristol Myers Squibb Company
FIG 21 Swot Analysis: Merck & Co., Inc.
FIG 22 Swot Analysis: AstraZeneca PLC
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Swot Analysis: Eli Lilly And Company
FIG 25 Recent strategies and developments: Pfizer, Inc.
FIG 26 Swot Analysis: Pfizer, Inc.
FIG 27 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 28 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 29 Swot Analysis: Johnson & Johnson
FIG 30 Swot Analysis: Amgen, Inc.
FIG 31 Swot Analysis: Sanofi S.A.
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo